Danapha Pharmaceutical JSC (HSTC:DAN) Stock Based Compensation: ₫0.00 Mil (TTM As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
31 GF Score
Price ₫32,800.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Stock Based Compensation?

Danapha Pharmaceutical JSC HSTC:DAN +10.81% 31 Stock Based Compensation is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Danapha Pharmaceutical JSC's Stock Based Compensation for the six months ended in . 20 was ₫0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC Stock Based Compensation Related Terms

Danapha Pharmaceutical JSC Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Stock Based Compensation Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Stock Based Compensation

Danapha Pharmaceutical JSC Semi-Annual Data
Stock Based Compensation
HSTC:DAN
31GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

What does a Stock Based Compensation of ₫0.00 Mil mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Stock Based Compensation of ₫0.00 Mil as of . 20. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Danapha Pharmaceutical JSC and its competitors.
Is Danapha Pharmaceutical JSC's Stock Based Compensation too high?
Danapha Pharmaceutical JSC's current Stock Based Compensation is ₫0.00 Mil. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Stock Based Compensation compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's Stock Based Compensation of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Danapha Pharmaceutical JSC and its competitors. Danapha Pharmaceutical JSC's current Stock Based Compensation is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Stock Based Compensation of ₫0.00 Mil. The current Stock Based Compensation is ₫0.00 Mil. Danapha Pharmaceutical JSC's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Stock Based Compensation is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
31GF Score

Get the complete analysis for HSTC:DAN

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫32,800.00
Price